An Educational Overview of SHINGRIX
Dear Snohomish County Healthcare Provider,
On October 25, 2017, the Advisory Committee on Immunization Practices (ACIP) issued the following recommendations for the use of Shingrix, a new vaccine licensed to prevent herpes zoster (shingles) and related complications:
- The vaccine may be used in immunocompetent adults aged 50 years and older.
- The vaccine may be administered even if the patient previously received Zoster Vaccine Live.
- Recombinant Zoster Vaccine is preferred for use over Zoster Vaccine Live.
Please join us on Thursday, May 10 for an Educational Overview of Shingrix, along with dinner, at Terracotta Red in Everett. Dr. Lisa Glasser, from GlaxoSmithKline, will be the evening’s presenter. See the attached invitation for more information. Please do not RSVP to this email.
More information about the recommendations for Herpes Zoster vaccines can be found online at https://www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm
We look forward to seeing you on May 10.
Snohomish Health District Health Officer
Dr Mark Beatty, MD, M.P.H.
And the Vaccine Preventable Disease Program Team
Susan Babcock, RN, BSN, Public Health Nurse
Kelly Barrows, Vaccine Coordinator
Mary O’Leary, M. Ed., Health Educator
Rita Mell, RN, BSN, Supervisor
Susan Ingram, Program Assistant
Sent at: 01:50:22 PM PDT